Understanding and managing the impact of the COVID-19 pandemic and lockdown on patients with epilepsy

Expert Rev Neurother. 2022 Feb;22(2):145-153. doi: 10.1080/14737175.2022.2031984. Epub 2022 Feb 7.

Abstract

Introduction: The coronavirus disease 2019 (COVID-19) pandemic represented a relevant issue for people with epilepsy (PwE). Medical care and social restrictions exposed PwE to a high risk of seizure worsening. Medical institutions answered to the pandemic assuring only emergency care and implementing a remote assistance that highlighted the technological obsolescence of the medical care paradigms for PwE.

Area covered: We reviewed the literature on the COVID-19-related factors influencing the epilepsy course, from the evidence of seizure risk in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infected PwE to anti-Sars-Cov-2 drugs interactions with antiseizure medications and the perceived changes of seizures in PwE.

Expert opinion: COVID-19 pandemic was a problematic experience for PwE. We must make treasure of the lessons learned during this period of social restrictions and employ the recent technological advances to improve PwE assistance, in particular telemedicine and electronic media for patients' education.

Keywords: COVID-19; anti-seizure medications; anxiety; depression; epilepsy; sleep; telemedicine.

Publication types

  • Review

MeSH terms

  • COVID-19*
  • Communicable Disease Control
  • Epilepsy* / drug therapy
  • Epilepsy* / therapy
  • Humans
  • Pandemics
  • SARS-CoV-2